Previous close | 3.1000 |
Open | 3.5600 |
Bid | 2.9500 |
Ask | 4.1500 |
Strike | 48.00 |
Expiry date | 2024-04-26 |
Day's range | 2.7300 - 3.9000 |
Contract range | N/A |
Volume | |
Open interest | 1.57k |
Biogen, Bristol Myers Squibb, Incyte and Vertex Pharmaceuticals are part of the Zacks top Analyst Blog.
PRINCETON, N.J., April 26, 2024--CHMP Adopts Positive Opinion Recommending Approval of Bristol Myers Squibb’s Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine....
A Strategic SWOT Insight into Bristol-Myers Squibb's Financials and Future